GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alkem Laboratories Ltd (NSE:ALKEM) » Definitions » Market Cap

Alkem Laboratories (NSE:ALKEM) Market Cap : ₹613,237 Mil (As of May. 11, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Alkem Laboratories Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Alkem Laboratories's share price for the quarter that ended in Dec. 2023 was ₹5202.6. Alkem Laboratories's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 120 Mil. Therefore, Alkem Laboratories's market cap for the quarter that ended in Dec. 2023 was ₹622,049 Mil.

Alkem Laboratories's quarterly market cap increased from Jun. 2023 (₹420,014 Mil) to Sep. 2023 (₹431,139 Mil) and increased from Sep. 2023 (₹431,139 Mil) to Dec. 2023 (₹622,049 Mil).

Alkem Laboratories's annual market cap increased from Mar. 2021 (₹331,171 Mil) to Mar. 2022 (₹432,909 Mil) but then declined from Mar. 2022 (₹432,909 Mil) to Mar. 2023 (₹406,055 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Alkem Laboratories's Enterprise Value for Today is ₹589,317 Mil.


Alkem Laboratories Market Cap Historical Data

The historical data trend for Alkem Laboratories's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alkem Laboratories Market Cap Chart

Alkem Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 209,340.38 278,090.26 331,171.14 432,909.00 406,054.70

Alkem Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 359,256.96 406,054.70 420,013.91 431,139.43 622,048.87

Competitive Comparison of Alkem Laboratories's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Alkem Laboratories's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alkem Laboratories's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alkem Laboratories's Market Cap distribution charts can be found below:

* The bar in red indicates where Alkem Laboratories's Market Cap falls into.



Alkem Laboratories Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Alkem Laboratories's Market Cap for the fiscal year that ended in Mar. 2023 is calculated as

Market Cap (A: Mar. 2023 )=Share Price (A: Mar. 2023 )*Shares Outstanding (EOP) (A: Mar. 2023 )
=₹3396.1*119.565
=₹406,055

Alkem Laboratories's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=₹5202.6*119.565
=₹622,049

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alkem Laboratories  (NSE:ALKEM) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Alkem Laboratories Market Cap Related Terms

Thank you for viewing the detailed overview of Alkem Laboratories's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Alkem Laboratories (NSE:ALKEM) Business Description

Traded in Other Exchanges
Address
Senapati Bapat Marg, Alkem House, Devashish Building, Lower Parel, Mumbai, MH, IND, 400 013
Alkem Laboratories Ltd is an Indian pharmaceutical company engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals in acute and chronic therapeutic areas, such as anti-infective, pain and analgesics, vitamins/minerals/nutrients, cardiac and Diabetology, Gynecology, neuro/central nervous system, dermatology, anti-diabetes, anti-osteoporosis, cardiovascular, and muscle relaxants, which are marketed in Indian and International markets. It operates through the pharmaceutical business segment.

Alkem Laboratories (NSE:ALKEM) Headlines

No Headlines